-
MRNA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Moderna (MRNA)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.93 bn | 1.93 bn | 1.93 bn | 1.93 bn | 1.93 bn | 1.93 bn |
Cash burn (monthly) | (no burn) | 83.25 mm | 415.33 mm | 328.75 mm | (no burn) | 250.33 mm |
Cash used (since last report) | n/a | 211.17 mm | 1.05 bn | 833.88 mm | n/a | 634.97 mm |
Cash remaining | n/a | 1.72 bn | 875.50 mm | 1.10 bn | n/a | 1.29 bn |
Runway (months of cash) | n/a | 20.6 | 2.1 | 3.3 | n/a | 5.2 |
13F holders | Current |
---|---|
Total holders | 729 |
Opened positions | 139 |
Closed positions | 192 |
Increased positions | 223 |
Reduced positions | 246 |
13F shares | Current |
---|---|
Total value | 11.21 tn |
Total shares | 303.04 mm |
Total puts | 24.11 mm |
Total calls | 18.96 mm |
Total put/call ratio | 1.3 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 40.32 mm | $1.68 tn |
Baillie Gifford & Co | 38.89 mm | $1.62 tn |
BlackRock | 25.79 mm | $1.07 tn |
FMR | 18.66 mm | $776.08 bn |
STT State Street | 17.58 mm | $730.67 bn |
Flagship Ventures Fund IV General Partner | 17.58 mm | $0.00 |
Bancel Stephane | 9.05 mm | $0.00 |
Theleme Partners | 7.31 mm | $303.82 bn |
Geode Capital Management | 7.24 mm | $300.22 bn |
UBS UBS | 5.07 mm | $210.95 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Mar 25 | Shannon Thyme Klinger | Common Stock | Payment of exercise | Dispose F | No | No | 34.3 | 551 | 18.90 k | 25,612 |
7 Mar 25 | Shannon Thyme Klinger | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,139 | 0.00 | 26,163 |
7 Mar 25 | Shannon Thyme Klinger | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 1,139 | 0.00 | 1,139 |
3 Mar 25 | Bancel Stephane | Common Stock | Buy | Acquire P | Yes | No | 31.53 | 57,493 | 1.81 mm | 9,210,686 |
3 Mar 25 | Bancel Stephane | Common Stock | Buy | Acquire P | Yes | No | 31.04 | 102,821 | 3.19 mm | 9,153,193 |
3 Mar 25 | Sagan Paul | Common Stock | Buy | Acquire P | Yes | No | 31.76 | 31,620 | 1.00 mm | 312,027 |
1 Mar 25 | Bancel Stephane | Stock Option Common Stock | Grant | Acquire A | No | No | 30.96 | 357,065 | 11.05 mm | 357,065 |
1 Mar 25 | Stephen Hoge | RSU Common Stock | Grant | Acquire A | No | No | 0 | 148,524 | 0.00 | 148,524 |
1 Mar 25 | Stephen Hoge | Stock Option Common Stock | Grant | Acquire A | No | No | 30.96 | 238,043 | 7.37 mm | 238,043 |
28 Feb 25 | Stephen Hoge | Common Stock | Payment of exercise | Dispose F | No | No | 31.09 | 296 | 9.20 k | 1,450,727 |